Pencol Pharmacy (Maplerose Enterprises, LLC), Denver, CO

Is Pencol Pharmacy (Maplerose Enterprises, LLC) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Pencol Pharmacy (Maplerose Enterprises, LLC) hold a Colorado pharmacy license?

No license with this exact name and city was found in the Colorado State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed.

Has Pencol Pharmacy (Maplerose Enterprises, LLC) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Mar 10, 2022), 1 untitled letter (Aug 18, 2020), 1 state referral letter (Mar 10, 2022) and 1 FMD-145 letter (Mar 10, 2022) for Pencol Pharmacy (Maplerose Enterprises, LLC). State board actions: no Colorado State Board of Pharmacy action under this exact name and city was found in the board’s license dataset (actions dated Oct 11, 1985 to Oct 30, 2026) on Nov 15, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Maplerose Enterprises, LLC; Pencol Pharmacy
Location
Denver, CO
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Mar 10, 2022
FDA Data Dashboard inspections
No matching site found
State board records
No exact match

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Maplerose Enterprises, LLC (dba Pencol Pharmacy), a 503A facility, with 5 dated actions.

Document
Mar 10, 2022State referral letterState Referral Letter Issued 03/10/2022Not linked by FDA
Mar 10, 2022FMD-145 letterFMD-145 Letter Issued 03/10/2022Not linked by FDA
Mar 10, 2022Warning letter close-outWarning Letter Close Out Issued 03/10/2022Not linked by FDA
Aug 18, 2020Untitled letterUntitled Letter Issued 08/18/2020FDA copy (archived)
Feb 26, 2019Amended Form 483Amended 483 Issued 02/26/2019FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

The dashboard does list Maple Rose Enterprises, Inc, Denver, CO (FEI 3012248071): same name and state, different city, so not treated as this site.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA links 1 Form 483 PDF for Pencol Pharmacy (Maplerose Enterprises, LLC), but no observation text is shown, for the reasons below.

Linked 483s whose text is not shown

State board of pharmacy records

No license with this exact name and city was found in the Colorado State Board of Pharmacy file dated Nov 15, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. Board file.

What this covers: Discipline the Department of Regulatory Agencies publishes with each license in the dataset (case number, program action and effective date), worded as the department gives it. Actions in the data are dated Oct 11, 1985 to Oct 30, 2026.

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.